A new trading day began on Friday, with Acelyrin Inc (NASDAQ: SLRN) stock price down -3.74% from the previous day of trading, before settling in for the closing price of $2.14. SLRN’s price has ranged from $1.91 to $8.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 53.95%. With a float of $73.18 million, this company’s outstanding shares have now reached $99.94 million.
The extent of productivity of a business whose workforce counts for 130 workers is very important to gauge. In terms of profitability, gross margin is -31.93%, operating margin of -202203.61%, and the pretax margin is -159280.12%.
Acelyrin Inc (SLRN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Acelyrin Inc is 27.06%, while institutional ownership is 69.54%. The most recent insider transaction that took place on Jul 17 ’24, was worth 7. In this transaction Director of this company sold 1 shares at a rate of $6.86, taking the stock ownership to the 2,999 shares. Before that another transaction happened on Apr 01 ’24, when Company’s Chief Executive Officer sold 9,961 for $6.63, making the entire transaction worth $66,024. This insider now owns 1,577,374 shares in total.
Acelyrin Inc (SLRN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.95% per share during the next fiscal year.
Acelyrin Inc (NASDAQ: SLRN) Trading Performance Indicators
Here are Acelyrin Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.68, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Acelyrin Inc (SLRN)
The latest stats from [Acelyrin Inc, SLRN] show that its last 5-days average volume of 4.2 million was superior to 3.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 9.97%. Additionally, its Average True Range was 0.40.
During the past 100 days, Acelyrin Inc’s (SLRN) raw stochastic average was set at 3.25%, which indicates a significant decrease from 7.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 206.18% in the past 14 days, which was higher than the 110.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.30, while its 200-day Moving Average is $4.86. Now, the first resistance to watch is $2.13. This is followed by the second major resistance level at $2.21. The third major resistance level sits at $2.26. If the price goes on to break the first support level at $2.00, it is likely to go to the next support level at $1.95. The third support level lies at $1.87 if the price breaches the second support level.
Acelyrin Inc (NASDAQ: SLRN) Key Stats
With a market capitalization of 206.67 million, the company has a total of 100,326K Shares Outstanding. Currently, annual sales are 0 K while annual income is -381,640 K. The company’s previous quarter sales were 0 K while its latest quarter income was -48,550 K.
